Table 1.
Unmet needs | More fitting solutions |
---|---|
Common barriers | |
Poor awareness of HCV screening in physicians and unawareness of HCV infection status in patients contribute to continued HCV transmission and missed prevention. | Adopt risk-based HCV testing in low- or middle-income countries, universal testing to targeted groups or general population in high-income countries. |
Promote periodly awareness campaigns for the public, educate at-risk populations and patients, provide professional training to health care workers. | |
Substantial participants do not link to care after screening. | Streamline the procedure of HCV cascade cure. |
Well-trained general practitioners charge for patients' screening, diagnosis and therapy. | |
Unique Barriers | |
Low-and middle-income countries | |
Limited health-care resource and insurance coverage schemes induce poor access to HCV test. | Request assistance from non-government foundations. |
A high proportion of individuals with HCV infection remain undiagnosed. | Adopt micro-elimination strategy in targeted populations, with gradual transition to universal screening. |
The lack of laboratory equipment and technology restricts the advantages of NAT. HCV screening of blood donors is inadequate. |
Choose easy-to-operate and highly sensitive screening assays, such as ELISA for serum antibody. |
Universal screening is rarely actualized before and during pregnancy. | Provide professional training to general practitioners. |
Work with obstetricians and select highly sensitive HCV antibody tests to promote testing for women of childbearing age or pregnancy. | |
High-income countries | |
Injection drug use (IDU) and Men who have sex with men (MSM) remain the key risk factor for new hepatitis C infections. | Promote HCV testing in PWID and increase access to harm reduction programs, such as needle exchange programs. |
Implement national HCV register to track progress and yearly screening. | |
Chances for screening are plentiful but no adequate linkage to care for sufficient treatment. | Take a holistic approach to HCV elimination with coordinated screening, linkage-to-care and treatment efforts. |